Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$2.96 USD
+0.06 (2.07%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $2.95 -0.01 (-0.34%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Balance Sheet
Fiscal Year End for Clover Health Investments, Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 243 | 335 | 615 | 28 | 0 |
Receivables | 81 | 94 | 62 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 104 | 196 | 75 | 0 | 0 |
Total Current Assets | 428 | 625 | 753 | 28 | 0 |
Net Property & Equipment | 5 | 6 | 2 | 0 | 0 |
Investments & Advances | 121 | 138 | 176 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 20 | 4 | 0 | 0 |
Deposits & Other Assets | 10 | 16 | 10 | 828 | 0 |
Total Assets | 571 | 809 | 951 | 856 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 37 | 32 | 28 | 0 | 0 |
Current Portion Long-Term Debt | 1 | 0 | 0 | 1 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 21 | 24 | 15 | 5 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 200 | 382 | 326 | 28 | 0 |
Total Current Liabilities | 261 | 441 | 373 | 34 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 29 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 20 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 20 | 16 | 14 | 789 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 284 | 461 | 411 | 851 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,461 | 2,319 | 2,154 | 12 | 0 |
Retained Earnings | -2,160 | -1,956 | -1,617 | -7 | 0 |
Other Equity | -2 | -9 | 2 | 0 | 0 |
Treasury Stock | 13 | 7 | 0 | 0 | 0 |
Total Shareholder's Equity | 286 | 348 | 539 | 5 | 0 |
Total Liabilities & Shareholder's Equity | 571 | 809 | 951 | 856 | 0 |
Total Common Equity | 286 | 348 | 539 | 5 | 0 |
Shares Outstanding | 489.00 | 478.30 | 470.80 | 24.60 | NA |
Book Value Per Share | 0.59 | 0.73 | 1.15 | 0.20 | 0.00 |
Fiscal Year End for Clover Health Investments, Corp falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 379 | 342 | 243 | 517 | 521 |
Receivables | 88 | 106 | 81 | 131 | 130 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 83 | 104 | 104 | 268 | 479 |
Total Current Assets | 550 | 553 | 428 | 916 | 1,129 |
Net Property & Equipment | 5 | 5 | 5 | 5 | 5 |
Investments & Advances | 104 | 98 | 121 | 102 | 86 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 3 | 3 | 19 | 19 |
Deposits & Other Assets | 10 | 10 | 10 | 15 | 15 |
Total Assets | 674 | 672 | 571 | 1,060 | 1,258 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 1 | 1 | 0 | 0 | 0 |
Accounts Payable | 40 | 35 | 37 | 35 | 40 |
Current Portion Long-Term Debt | 0 | 0 | 1 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 32 | 28 | 21 | 24 | 20 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 249 | 290 | 200 | 657 | 846 |
Total Current Liabilities | 325 | 356 | 261 | 719 | 908 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 22 | 20 | 16 | 16 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 349 | 379 | 284 | 738 | 927 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,518 | 2,490 | 2,461 | 2,428 | 2,395 |
Retained Earnings | -2,172 | -2,179 | -2,160 | -2,089 | -2,048 |
Other Equity | -2 | -3 | -2 | -5 | -7 |
Treasury Stock | 19 | 16 | 13 | 12 | 10 |
Total Shareholder's Equity | 325 | 292 | 286 | 322 | 331 |
Total Liabilities & Shareholder's Equity | 674 | 672 | 571 | 1,060 | 1,258 |
Total Common Equity | 325 | 292 | 286 | 322 | 331 |
Shares Outstanding | 496.10 | 496.40 | 489.00 | 487.20 | 483.60 |
Book Value Per Share | 0.65 | 0.59 | 0.59 | 0.66 | 0.68 |